2071 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Zelenetz
    Zelenetz
  4. Yahalom
    Yahalom
  5. Cheung
    Cheung
  6. O'Reilly
    O'Reilly
  7. Kushner
    Kushner
  8. Perales
    Perales
  9. La Quaglia
    La Quaglia
  10. Giralt
    Giralt

Groups

  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)
  7. Surgery (287)
  8. GSK Faculty (276)
  9. Breast Medicine Service (255)
  10. Tow Center for Developmental Oncology (TCDO) (240)
  1. "cyclophosphamide"
Formats
  1. Journal Article (1932)
  2. Review (52)
  3. Conference Paper (46)
  4. Editorial (11)
  5. Research Letter (11)
  6. Meeting Abstract (8)
  7. Correspondence (6)
  8. Guidelines (4)
  9. Book Section (1)
Groups
  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)

More Groups

People
  1. Clifford Hudis (130)
  2. Larry Norton (104)
  3. Andrew Zelenetz (75)
  4. Joachim Yahalom (72)
  5. Nai-Kong Cheung (71)
  6. Richard O'Reilly (67)

More People

Years
  1. 2025 (45)
  2. 2024 (86)
  3. 2023 (56)
  4. 2022 (44)
  5. 2021 (23)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer (109)
  3. Blood (81)
  4. Leukemia and Lymphoma (50)
  5. Biology of Blood and Marrow Transplantation (49)
  6. Bone Marrow Transplantation (48)

More Publications

Publishers
  1. Elsevier Inc. (345)
  2. American Society of Clinical Oncology (163)
  3. Wiley Blackwell (150)
  4. Springer (147)
  5. American Society of Hematology (113)
  6. Lippincott Williams & Wilkins (112)

More Publishers

Results (2071)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Journal Article

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; O’Dwyer, K. M.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Allogeneic chimeric antigen receptor T-cell products cemacabtagene ansegedleucel/ALLO-501 in relapsed/refractory large B-cell lymphoma: Phase I experience from the ALPHA2/ALPHA clinical studies
    Journal Article

    Locke, F. L.; Munoz, J. L.; Tees, M. T.; Lekakis, L. J.; de Vos, S.; Nath, R.; Stevens, D. A.; Malik, S. A.; Shouse, G. P.; Hamadani, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS)
    Review

    Lee, J. C.; Johnson, W. T.; Hines, M.; Shah, N. N.
    Hematology/Oncology Clinics of North America (2025)

    Fulltext@MSK | Save
  • Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Journal Article

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • MEIS1::NCOA1 primitive spindle cell sarcoma of the kidney: Report of 7 cases of a distinctive clinicopathologic entity
    Journal Article

    Argani, P.; Wangsiricharoen, S.; Tretiakova, M.; Liu, Y. J.; Falzarano, S. M.; Collins, K.; Brimo, F.; Gross, J. M.; Baraban, E.; Matoso, A.; more...
    American Journal of Surgical Pathology (2025)

    Fulltext@MSK | Save
  • Predicting progression events in multiple myeloma from routine blood work
    Journal Article

    Ferle, M.; Grieb, N.; Kreuz, M.; Ader, J.; Goldschmidt, H.; Mai, E. K.; Bertsch, U.; Platzbecker, U.; Neumuth, T.; Reiche, K.; more...
    npj Digital Medicine (2025)

    Fulltext@MSK | Save
  • Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: A first-in-human, single-centre, phase 1 trial
    Journal Article

    Lou, E.; Choudhry, M. S.; Starr, T. K.; Folsom, T. D.; Bell, J.; Rathmann, B.; DeFeo, A. P.; Kim, J.; Slipek, N.; Jin, Z.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - A US multisite study
    Correspondence

    Epperla, N.; Shouse, G.; Grover, N. S.; Torka, P.; Annunzio, K.; Watkins, M.; Anampa-Guzmán, A.; Christian, B.; Thomas, C.; Barta, S. K.; more...
    Experimental Hematology and Oncology (2025)

    Fulltext@MSK | Save
  • Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes: Hypogammaglobulinemia after rituximab in children
    Journal Article

    Höppener, S. P. C.; Veldkamp, S. R.; de Groot, M. C. H.; Haitjema, S.; Drylewicz, J.; Boelens, J. J.; Lindemans, C. A.; van Montfrans, J.; van Royen-Kerkhof, A.; Jansen, M. H. A.
    Clinical Immunology Communications (2025)

    Fulltext@MSK | Save
  • Bodyweight and absolute lymphocyte count-based dosing of rabbit anti-thymocyte globulin results in early CD4+ immune reconstitution in patients with inborn errors of metabolism undergoing umbilical cord blood transplantation
    Journal Article

    Drozdov, D.; Kandil, J.; Long, S. E.; Demorest, C. V.; Cao, Q.; Lund, T. C.; Gupta, A. O.; Boelens, J. J.; Orchard, P. J.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save